NOTCH1 Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study

Documenti analoghi

• Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia
  di: Fiona Fernando, et al.
  Pubblicazione: (2025)
• Prescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany
  di: Marek Lapka, et al.
  Pubblicazione: (2026)
• Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge
  di: Matthew T. Ye, et al.
  Pubblicazione: (2026)
• Epidemiology, Survival, and Second Primary Malignancies in T‐Cell Large Granular Lymphocytic Leukemia
  di: Arya Mariam Roy, et al.
  Pubblicazione: (2025)
• Rod‐Like Cytoplasmic Inclusions in the Peripheral Blood Smear of a Patient with Chronic Lymphocytic Leukemia
  di: Abhishek Prasad, et al.
  Pubblicazione: (2026)